Sinocelltech Group Ltd

688520

Company Profile

  • Business description

    Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

  • Contact

    Kechuang Seventh Street
    Beijing Economic and Technological Development Zone
    Room 307, Building 5, Courtyard 31
    Beijing100176
    CHN

    T: +86 1058628288

    http://www.sinocelltech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    2,277

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,910.4019.50-0.22%
CAC 408,124.8856.260.70%
DAX 4024,229.9143.420.18%
Dow JONES (US)48,416.5641.49-0.09%
FTSE 1009,751.31102.281.06%
HKSE25,349.05279.83-1.09%
NASDAQ23,057.41137.76-0.59%
Nikkei 22549,515.14652.97-1.30%
NZX 50 Index13,425.8117.670.13%
S&P 5006,816.5110.90-0.16%
S&P/ASX 2008,628.2019.10-0.22%
SSE Composite Index3,835.7132.21-0.83%

Market Movers